Taysha Gene Therapies Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Taysha Gene Therapies Inc
TickerTSHA
CIK #0001806310
CUSIP877619106
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address7318 Morton Street, Dallas, TX 75209
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Taysha Gene Therapies Inc 2023-08-25 150.0 M Exemption: 506(b) · Remaining: $44,251 · Duration: One year or less · Finder's Fee: $9,000,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001806310] 10-K
[0001806310] 10-Q
[0001806310] 3
[0001806310] 4
[0001806310] 5
[0001806310] 8-K
[0001806310] D
[0001806310] SC 13D
[0001806310] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vestal Point Capital LP Taysha Gene Therapies Inc [2026-02-17] 0.0
Goldman Sachs Group Inc Taysha Gene Therapies Inc [2025-07-03] 0.0
Morgan Stanley Taysha Gene Therapies Inc [2025-02-05] 0.0
Octagon Capital Advisors LP Taysha Gene Therapies Inc [2025-02-05] 0.0
Avoro Capital Advisors LLC Taysha Gene Therapies Inc [2024-11-14] 0.99
BlackRock Inc Taysha Gene Therapies Inc [2024-11-08] 6.6
BlackRock Inc Taysha Gene Therapies Inc [2024-10-22] 6.6
RTW Investments LP Taysha Gene Therapies Inc [2024-02-14] 0.8
Venrock Healthcare Capital Partners III LP Taysha Gene Therapies Inc [2023-08-28] 7.7
TCG Crossover GP I LLC Taysha Gene Therapies Inc [2023-08-25] 5.9
RA Capital Management LP Taysha Gene Therapies Inc [2023-08-25] 9.99
Audentes Therapeutics Inc Taysha Gene Therapies Inc [2022-10-31] 11.6
BlackRock Inc Taysha Gene Therapies Inc [2022-07-08] 2.6
University of Texas/Texas AM Investment Managment Co Taysha Gene Therapies Inc [2021-09-24] 3.01
University of Texas/Texas AM Investment Managment Co Taysha Gene Therapies Inc [2021-02-16] 5.77
BlackRock Inc Taysha Gene Therapies Inc [2021-02-02] 5.9
FMR LLC Taysha Gene Therapies Inc [2020-10-13] 0.0
Session RA II Taysha Gene Therapies Inc [2020-10-05] 25.5
Manning Paul B Taysha Gene Therapies Inc [2020-10-05] 14.3
Form 3/4/5 Filer 2011 - 2026
Sepp-Lorenzino Laura
Taysha Gene Therapies Inc
Donenberg Philip B
Long Alison S
Stalfort John A III
Nagendran Sukumar
Alam Kamran
Nolan Sean P
Manning Paul B
Session RA II
Reape Kathleen
Audentes Therapeutics Inc
Astellas Pharma Inc
Prasad Suyash
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Alam Kamran
Common Stock
2026-02-04 Sell 1,655 $4.52 7,481
Alam Kamran
Common Stock
2026-01-26 Sell 23,849 $4.61 109,944
Nagendran Sukumar
Common Stock
2026-01-26 Sell 26,918 $4.61 124,092
Nolan Sean P
Common Stock
2026-01-26 Sell 41,312 $4.61 190,448
Nagendran Sukumar
Common Stock
2026-01-23 Sell 89,132 $4.75 423,377
Nolan Sean P
Common Stock
2026-01-23 Sell 136,789 $4.75 649,748
Alam Kamran
Common Stock
2026-01-23 Sell 78,968 $4.75 375,098
Alam Kamran
Employee Stock Option (right to buy) · derivative
2026-01-12 Grant 231,000 $0.00
Nolan Sean P
Employee Stock Option (right to buy) · derivative
2026-01-12 Grant 648,000 $0.00
Nagendran Sukumar
Employee Stock Option (right to buy) · derivative
2026-01-12 Option exercise 88,676 $0.00
Nagendran Sukumar
Employee Stock Option (right to buy) · derivative
2026-01-12 Grant 274,000 $0.00
Nagendran Sukumar
Employee Stock Option (right to buy) · derivative
2026-01-12 Option exercise 111,324 $0.00
Alam Kamran
Common Stock
2026-01-12 Grant 359,000 $0.00
Nolan Sean P
Common Stock
2026-01-12 Grant 1,008,000 $0.00
Nagendran Sukumar
Common Stock
2026-01-12 Option exercise 88,676 $1.71 151,636
Nagendran Sukumar
Common Stock
2026-01-12 Option exercise 111,324 $0.70 77,927
Nagendran Sukumar
Common Stock
2026-01-12 Sell 200,000 $4.71 942,000
Nagendran Sukumar
Common Stock
2026-01-12 Grant 427,000 $0.00
Nagendran Sukumar
Common Stock
2025-12-01 Sell 260,047 $4.51 1,172,812
Nagendran Sukumar
Common Stock
2025-12-01 Option exercise 260,047 $1.71 444,680
showing 20 of 174 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 193 263,866,951
2025-12-31 197 269,148,116
2025-09-30 155 265,674,347
2025-06-30 150 258,280,073
2025-03-31 128 166,837,925
2024-12-31 131 167,247,810
2024-09-30 121 160,060,905
2024-06-30 108 161,223,366
2024-03-31 111 150,467,709
2023-12-31 88 130,539,737
2023-09-30 66 130,211,069
2023-06-30 40 13,706,987
Form 13F Holdings
Firm Period DFND Voting Shares
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 519,120 519,120
Williams & Novak LLC [2026-06-30] SOLE 0 45,000
Gamma Investing LLC [2026-06-30] DFND 232 232
Capital Advisors Ltd LLC [2026-06-30] SOLE 0 79
Farther Finance Advisors LLC [2026-06-30] SOLE 0 55
True Wealth Design LLC [2026-06-30] SOLE 0 30
IFP Advisors LLC [2026-06-30] SOLE 14 14
Hughes Financial Services LLC [2026-06-30] SOLE 6 6
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com